BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27451978)

  • 21. Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients.
    Abaji R; Gagné V; Xu CJ; Spinella JF; Ceppi F; Laverdière C; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
    Oncotarget; 2017 Jul; 8(27):43752-43767. PubMed ID: 28574850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
    Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful Management of l-Asparaginase-Associated Pancreatitis With Octreotide and Pegylated Asparaginase in 2 Patients With Acute Lymphoblastic Leukemia: Is There a Different Rare Warning Sign of Hypoglycemia for l-Asparaginase-Associated Pancreatitis?
    Aydin Köker S; Oymak Y; Demirağ B; Karapinar TH; Koker A; Genç S; Erdemir G; Vergin RC
    Clin Ther; 2020 Apr; 42(4):e82-e86. PubMed ID: 32184014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study.
    Lynggaard LS; Rank CU; Hansen SN; Gottschalk Højfeldt S; Henriksen LT; Jarvis KB; Ranta S; Niinimäki R; Harila-Saari A; Wolthers BO; Frandsen TL; Heyman M; Schmiegelow K; Albertsen BK
    Blood Adv; 2022 Jan; 6(1):138-147. PubMed ID: 34625787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol.
    Wang J; Jia WG; Yang LH; Kuang WY; Huang LB; Chen HQ; Wang LN; Zhou DH; Liao N
    Hematology; 2023 Dec; 28(1):2171723. PubMed ID: 36752506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia.
    Sahu S; Saika S; Pai SK; Advani SH
    Pediatr Hematol Oncol; 1998; 15(6):533-8. PubMed ID: 9842647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia.
    Tong WH; Pieters R; de Groot-Kruseman HA; Hop WC; Boos J; Tissing WJ; van der Sluis IM
    Haematologica; 2014 Nov; 99(11):1716-21. PubMed ID: 25150254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting asparaginase-associated pancreatitis.
    Knoderer HM; Robarge J; Flockhart DA
    Pediatr Blood Cancer; 2007 Oct; 49(5):634-9. PubMed ID: 16937362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acid-suppressing Drugs and a Low 1 Level of Antithrombin as Risk Factors for L-Asparaginase-associated Pancreatitis: A Case-control Study in the Japan Association of Childhood Leukemia Study (JACLS).
    Hashii Y; Yoshida M; Hara J; Nishimura S; Yumura-Yagi K; Horibe K; Nakahata T
    J Pediatr Hematol Oncol; 2018 Jul; 40(5):374-378. PubMed ID: 29697579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia.
    Rajić V; Debeljak M; Goričar K; Jazbec J
    Leuk Lymphoma; 2015; 56(11):3103-8. PubMed ID: 25697915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-dependent diabetes: A chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia.
    Wolthers BO; Mogensen PR; Frandsen TL; Abrahamsson J; Behrendtz M; Heyman M; Lohi O; Norén-Nyström U; Ruud E; Schmiegelow K
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27437. PubMed ID: 30216644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity.
    Kutszegi N; Semsei ÁF; Gézsi A; Sági JC; Nagy V; Csordás K; Jakab Z; Lautner-Csorba O; Gábor KM; Kovács GT; Erdélyi DJ; Szalai C
    PLoS One; 2015; 10(10):e0140136. PubMed ID: 26457809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between modified CT severity index and clinical features of L-asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia.
    Oh HJ; Im SA; Lee JW; Chung NG; Cho B
    Pediatr Hematol Oncol; 2014 Oct; 31(7):647-55. PubMed ID: 24933500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute pancreatitis during chemotherapy of acute lymphoblastic leukaemia complicated with pseudocyst].
    Sikorska-Fic B; Stańczak E; Matysiak M; Kamiński A
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1051-5. PubMed ID: 19531825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity as a predictor of treatment-related toxicity in children with acute lymphoblastic leukaemia.
    Egnell C; Heyman M; Jónsson ÓG; Raja RA; Niinimäki R; Albertsen BK; Schmiegelow K; Stabell N; Vaitkeviciene G; Lepik K; Harila-Saari A; Ranta S
    Br J Haematol; 2022 Mar; 196(5):1239-1247. PubMed ID: 34726257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives.
    Gibson A; Hernandez C; Tejada FNH; Kawedia J; Rytting M; Cuglievan B
    Paediatr Drugs; 2021 Sep; 23(5):457-463. PubMed ID: 34351604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
    Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis.
    Kearney SL; Dahlberg SE; Levy DE; Voss SD; Sallan SE; Silverman LB
    Pediatr Blood Cancer; 2009 Aug; 53(2):162-7. PubMed ID: 19405141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
    Tuckuviene R; Ranta S; Albertsen BK; Andersson NG; Bendtsen MD; Frisk T; Gunnes MW; Helgestad J; Heyman MM; Jonsson OG; Mäkipernaa A; Pruunsild K; Tedgård U; Trakymiene SS; Ruud E
    J Thromb Haemost; 2016 Mar; 14(3):485-94. PubMed ID: 26707629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study.
    Zhang YY; Yang QS; Qing X; Li BR; Qian J; Wang Y; Ning BT
    Front Oncol; 2020; 10():538779. PubMed ID: 33194600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.